Stocks and Investing
Stocks and Investing
Fri, December 16, 2022
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Kevin Fischbeck Upgraded (UHS) to Hold and Increased Target to $145 on, Dec 16th, 2022
Kevin Fischbeck of B of A Securities, Upgraded "Universal Health Services, Inc." (UHS) to Hold and Increased Target from $120 to $145 on, Dec 16th, 2022.
Kevin has made no other calls on UHS in the last 4 months.
There are 5 other peers that have a rating on UHS. Out of the 5 peers that are also analyzing UHS, 1 agrees with Kevin's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $114 on, Thursday, October 27th, 2022
These are the ratings of the 4 analyists that currently disagree with Kevin
- Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $144 on, Wednesday, December 14th, 2022
- Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $157 on, Friday, November 25th, 2022
- Andrew Mok of "UBS" Maintained at Strong Sell with Increased Target to $113 on, Monday, November 14th, 2022
- Jamie Perse of "Goldman Sachs" Maintained at Strong Sell with Increased Target to $121 on, Tuesday, November 1st, 2022
Contributing Sources